Fmoc-His-Aib-OH is a protected dipeptide building block used in solid-phase peptide synthesis. It consists of an N-terminal Fmoc-protected histidine linked to an alpha-methylalanine (Aib) residue, which introduces conformational constraints into peptide sequences.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1446013-07-5
N-Boc-4-hydroxy-D-proline, trans-
Peptide synthesis intermediate
(2S)-2-{[(tert-butoxy)carbonyl]amino}pentanedioic acid
Peptide synthesis intermediate
FMOC-DAB(Z)-OH
Peptide synthesis intermediate
L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-
Peptide synthesis intermediate
2-(1-(1-Methylethyl)-1H-pyrazol-5-yl)-3-pyridinemethanol
voxelotor synthetic intermediate
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate synthesis
6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
pharmaceutical intermediate
Tert-Butyl 2-cyanopyrrolidine-1-carboxylate
Pharmaceutical intermediate for pyrrolidine derivatives
2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoic acid
DRXNKOXLDLFGEG-NRFANRHFSA-N
CC(C)(C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24